According to the Australian Journal of General Practice, published by the Royal Australian College of General Practitioners, more than 130,000 medicinal cannabis approvals have been issued in Australia to date, mostly by general practitioners, with approximately 65% of these to treat chronic non-cancer pain. Despite robust supportive data from animal models, current clinical trial evidence for THC and CBD efficacy in chronic pain is incomplete. In their prescribing decisions, doctors must balance patient demand and curiosity with caution regarding potential risks and limited efficacy (Source: https://www1.racgp.org.au/ajgp/2021/october/medicinal-cannabis)
Australian Health Journal met with 3 speakers at the recent @arcsaustralia ARCS22 Conference providing an update on medicinal cannabis. The discussion with the speakers now centres on affordability and access.
-
Sonia Marshall – South Western Sydney Local Health District
South Western Sydney Local Health District serves nearly 1 million people in a rapidly growing area of Sydney. Currently 250-300 families a week are moving into the region and with a growing population, the health district requires well executed strategy and delivery of healthcare to the population. Executive Director Sonia Marshall spoke with Australian Health Journal reporter Anne Dao at last week’s Australian Healthcare Week in Sydney, on supporting staff and the community. Sonia highlights the mission of delivering Safe Quality Healthcare at all times. In-time patient feedback is important and the SWSLHD has implemented a system called “My Experience Matters” to give near immediate response from patients on their level of care, whilst they are still on site at the hospital. The aim of the initiative is to quickly identify bad experiences that could be rectified.
-
Surgical Site Infection (SSI) Synopsis, including modifiable and non-modifiable risk factors
Talking to the Australian Health Journal, Professor Russo states there is a particular concern in joint operations, such as hip or knee replacements, as infections in these areas can have severe consequences, including the removal of the infected joint, prolonged treatment, and significant costs for both hospitals and patients. Despite the substantial impact of surgical site infections, Australia lacks a national surveillance program for these infections, making it challenging to obtain accurate data. However, an estimate suggests that around 45,000 surgical site infections occur annually in Australia, resulting in approximately 900 deaths.
-
Expansion of specialist training in regional & rural areas
Associate Professor Sanjay Jeganathan, Chair of the Council of Presidents of Medical Colleges (CPMC) states, ”Our rural and regional communities deserve the same access to specialist care as our cities. We’re seeing real results from our colleges’ commitment to rural training.”
